Bismuth and Non-bismuth Quadruple Therapy for Helicobacter pylori Eradication: Time to Make the Switch in Clinical Practice?

Gastroenterology. 2017 Jan;152(1):301-302. doi: 10.1053/j.gastro.2016.06.058. Epub 2016 Nov 27.

Authors

Jyh-Ming Liou¹, Jaw-Town Lin², Ming-Shiang Wu¹

Affiliations

¹ Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.
² Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei and College of Medicine, Fu-Ren Catholic University and Big Data Research Centre, Fu-Ren Catholic University, New Taipei City, Taiwan.

PMID: 27899016
DOI: 10.1053/j.gastro.2016.06.058

No abstract available

Publication types

Letter
Comment

MeSH terms

Amoxicillin
Antacids
Anti-Bacterial Agents
Antidiarrheals
Bismuth*
Drug Therapy, Combination
Helicobacter Infections
Helicobacter pylori*
Humans
Metronidazole
Treatment Outcome

Substances

Antacids
Anti-Bacterial Agents
Antidiarrheals
Metronidazole
Amoxicillin
Bismuth